Canadians affected by prescription drug Rexulti could receive thousands in a $4.75-million settlement, and the deadline to file a claim is just months away. In November, the Consumer Law Group announced that the Superior Court of Quebec approved a Canada-wide class-action settlement of $4.75 million “that will be used to pay compensation for persons that file valid, timely, and approved claims.” Eligible Canadians have until Aug. 1, 2026, to file a claim. THE ALLEGATIONS Law firm of Rochon Genov